BRAF and melanoma: Furthermore, we evaluated the prognostic factors for advanced BRAF-mutated melanoma patients; we found that ECOG PS≥2, presence of liver metastases, and high LDH level from initiation of first-line treatment were all associated with differences in PFS and OS.